Zolpidem, but lemborexant more consistently, showed self-reported and objective benefits compared with placebo in insomnia patients with sleep duration of less than 6 hours per nightCommentary on Inoue Y, Nishida M, Kubota N, et al. Comparison of the treatment effectiveness between lemborexant and zolpidem tartrate extended release for insomnia disorder subtypes defined based on polysomnographic findings. J Clin Sleep Med . 2023;19(3):519–528. doi: 10.5664/jcsm.10378

Autor:	Alen Juginović
Rok vydání:	2023
Předmět:	Pulmonary and Respiratory Medicine Neurology Neurology (clinical)
Zdroj:	Journal of Clinical Sleep Medicine. 19:429-430
ISSN:	1550-9397 1550-9389
DOI:	10.5664/jcsm.10458
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::2d93c325961dae03ff9198e7be761ea1 https://doi.org/10.5664/jcsm.10458 Zobrazit plný text záznamu